Chemicals

DL-Homocysteinethiolactone hydrochloride

We are DL-Homocysteinethiolactone hydrochloride CAS:6038-19-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 6038-19-3

Product Name: DL-Homocysteinethiolactone hydrochloride

Other Name:

3-Aminodihydro-2(3H)-thiophenone hydrochloride

Homocysteine thiolactone hydrochloride

3-Aminodihydrothiophen-2(3H)-one hydrochloride

1,4-thiolactone hydrochloride

D,L-homocysteine thiolactone hydrochloride

Density: 0.862 g/cm3

Boiling Point: 253.8ºC at 760 mmHg

Melting Point: 202 °C (dec.)(lit.)

Molecular Formula: C4H8ClNOS

Molecular Weight: 153.630

Flash Point: 107.3ºC

Exact Mass: 153.001511

PSA: 68.39000

LogP: 1.47950

Water Solubility: 740.5 g/L (20 C)

Specification

Appearance: White Crystalline Powder

Assay: ≥99.0%

Loss on drying: ≤0.5%

Acidity: ≤0.5%

Application

Intermediates of Erdosteine CAS: 84611-23-4.

Be used as pharmaceutical intermediate, mainly used in the synthesis of Erdosteine.

Package: 25kg/drum, can also be designed according to customer requirements.

Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

DL-Homocysteinethiolactone hydrochloride

Related News: Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.4-Chloro-2-fluorotoluene At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content.2-(4-aminomethylphenyl)benzamide The fine and functional chemicals sector provides new growth drivers.4- (2-metoxietil) fenol CAS:56718-71-9 The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.

Product Name
CAS:69094-18-4 Bropol	View Details
Ethyl 5-amino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate	View Details
(5R-cis)-Toluene-4-sulfonic Acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl Ester Cas:149809-43-8	View Details